LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 3.66 | 27.76 | 676 | 283 | 2.3809 | 1.5902 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.36 | 27.76 | 635 | 320 | 1.9822 | 1.4279 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.36 | 27.76 | 760 | 320 | 2.3724 | 1.5548 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.06 | 27.76 | 697 | 360 | 1.9361 | 1.3913 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.06 | 27.76 | 3 | 360 | 0.0083 | -0.4522 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.06 | 27.76 | 847 | 360 | 2.3528 | 1.5208 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.76 | 27.76 | 752 | 401 | 1.8746 | 1.3543 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.76 | 27.76 | 4 | 401 | 0.0100 | -0.3952 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 8.76 | 27.76 | 892 | 401 | 2.2236 | 1.4610 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.46 | 27.76 | 818 | 438 | 1.8648 | 1.3388 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.46 | 27.76 | 12 | 438 | 0.0274 | -0.1899 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.46 | 27.76 | 949 | 438 | 2.1635 | 1.4277 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.17 | 27.76 | 845 | 489 | 1.7278 | 1.2825 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.17 | 27.76 | 14 | 489 | 0.0286 | -0.1524 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.17 | 27.76 | 1003 | 489 | 2.0508 | 1.3790 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.87 | 27.76 | 5 | 604 | 0.0083 | -0.3200 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.87 | 27.76 | 888 | 604 | 1.4685 | 1.1806 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.87 | 27.76 | 16 | 604 | 0.0265 | -0.1166 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.87 | 27.76 | 1007 | 604 | 1.6652 | 1.2431 | MN20160318_Q01 | N12 |